j.nascimento
TL2 Moderator · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 7 January 2025 · last posted 19h
83 posts, newest first. Showing up to 150.
-
Revisiting: What pooling buys you and what it destroys Replied, post #108 · Evidence › Meta-analyses · 27 Jul 2026 · 11 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #28 · Outcomes › Progress reports · 27 Jul 2026 · 1 like Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Forced degradation studies: designing one that is informative Replied, post #105 · Analytics › Method validation · 24 Jul 2026 · 24 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #92 · Wellbeing › Sleep · 22 Jul 2026 · 24 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
What a reversed-phase purity number actually is Replied, post #50 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 8 likes post #49 answers the question as asked. The question underneath it is different. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #95 · Compounds › Semaglutide · 8 Jul 2026 · 4 likes Coming back to post #93, because the follow-up matters more than the original answer. Gastric emptying delay is the mechanism behind most of the gastrointestinal side…
-
Publication patterns in the BPC-157 literature, examined Replied, post #29 · Compounds › Repair & healing peptides · 6 Jul 2026 · 0 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #54 · Analytics › Home & field testing · 5 Jul 2026 · 1 like I read post #52 twice before replying, because I had assumed the opposite. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #27 · Compounds › Retatrutide · 30 Jun 2026 · 0 likes This follows post #24 rather than contradicting it. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the…
-
Submitting a sample: the process end to end Replied, post #26 · Sourcing › Independent verification · 19 Jun 2026 · 0 likes Worth separating two things that post #22 runs together. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
A site rotation scheme that is easy enough to actually follow Replied, post #90 · Practice › Administration · 16 Jun 2026 · 18 likes I read post #88 twice before replying, because I had assumed the opposite. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer…
-
Racemisation and why it is invisible to a mass measurement Replied, post #29 · Analytics › Impurities & related substances · 10 Jun 2026 · 0 likes This follows post #26 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
-
Revisiting: What pooling buys you and what it destroys Replied, post #41 · Evidence › Meta-analyses · 2 Jun 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #40 · Safety › Contraindications · 16 May 2026 · 2 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
When a dose reduction is the correct response to a side effect Replied, post #20 · Practice › Dosing & titration · 13 May 2026 · 0 likes This follows post #17 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
-
Injection volume, overload, and peak distortion Replied, post #3 · Analytics › HPLC & UHPLC · 10 May 2026 · 13 likes This follows post #2 rather than contradicting it. System suitability testing: injections run before and during the sample run to establish whether the instrument,…
-
Transporting a vial for a weekend away — a second dataset Replied, post #18 · Practice › Storage & stability · 1 Apr 2026 · 32 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #22 · Analytics › Impurities & related substances · 31 Mar 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #71 · Lounge › Introductions · 15 Mar 2026 · 9 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
-
Which fields on a certificate actually matter, ranked Replied, post #3 · Analytics › COA interpretation · 10 Mar 2026 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #36 · Compounds › Semaglutide · 26 Feb 2026 · 29 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Second pass at: Identical chromatograms across two different lots Replied, post #29 · Sourcing › Red flags · 26 Feb 2026 · 1 like Picking up post #26: that is the part I would want checked first. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #43 · Data & Tools › Calculators · 25 Feb 2026 · 3 likes post #42 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Measurement error in a self-reported exposure Replied, post #60 · Evidence › Study critique · 25 Feb 2026 · 11 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #23 · Practice › Administration · 23 Feb 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #89 · Pharmacology › Pharmacokinetics · 22 Feb 2026 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #86 · Outcomes › Progress reports · 19 Feb 2026 · 24 likes I read post #84 twice before replying, because I had assumed the opposite. Medication changes: escalating dose, or adding or removing other medications, can affect the…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #65 · Outcomes › Progress reports · 16 Feb 2026 · 18 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Blinding yourself: practical methods and their limits Replied, post #4 · Research Methods › N-of-1 designs · 7 Feb 2026 · 0 likes Worth separating two things that post #3 runs together. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #88 · Practice › Side effects · 13 Jan 2026 · 2 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #63 · Practice › Side effects · 9 Jan 2026 · 0 likes Coming back to post #61, because the follow-up matters more than the original answer. Nausea: the most common side effect and the most dose- and titration-dependent…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #11 · Compounds › Tirzepatide · 9 Jan 2026 · 7 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Filter needles: when they help and what they cost you Replied, post #20 · Devices › Syringes & needles · 6 Jan 2026 · 0 likes post #19 answers the question as asked. The question underneath it is different. Sharps disposal: needles and syringes should be disposed in a sharps container (a…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #11 · Practice › Administration · 3 Jan 2026 · 28 likes This follows post #8 rather than contradicting it. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #7 · Analytics › HPLC & UHPLC · 1 Jan 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
-
Prescription requirements and telehealth models Replied, post #92 · Sourcing › Regulatory · 26 Dec 2025 · 10 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Tracking that stops updating and then resumes — the long version Replied, post #54 · Sourcing › Logistics · 20 Dec 2025 · 25 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #5 · Compounds › Secretagogues & GH axis · 19 Dec 2025 · 0 likes Worth separating two things that the opening post runs together. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #18 · Compounds › Retatrutide · 8 Dec 2025 · 1 like Picking up post #15: that is the part I would want checked first. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #18 · Data & Tools › Calculators · 25 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #84 · Analytics › HPLC & UHPLC · 18 Nov 2025 · 0 likes Worth separating two things that post #80 runs together. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #4 · Compounds › Oral incretins · 30 Oct 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Reading SURMOUNT-1 without the press release Replied, post #48 · Compounds › Tirzepatide · 29 Oct 2025 · 3 likes I read post #46 twice before replying, because I had assumed the opposite. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #110 · Practice › Administration · 14 Oct 2025 · 24 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #7 · Analytics › HPLC & UHPLC · 21 Sep 2025 · 9 likes post #6 answers the question as asked. The question underneath it is different. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #19 · Practice › Interactions · 19 Sep 2025 · 0 likes Coming back to post #17, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #120 · Data & Tools › Calculators · 18 Sep 2025 · 7 likes post #119 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #66 · Evidence › Study critique · 14 Sep 2025 · 21 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Titles that describe the question, not the situation — what changed since Replied, post #6 · Start Here › How to Ask · 10 Sep 2025 · 7 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #32 · Practice › Storage & stability · 23 Aug 2025 · 7 likes post #31 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #5 · Analytics › COA interpretation · 19 Aug 2025 · 0 likes Picking up post #2: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Hypertension improvement and when medication needs revisiting Replied, post #15 · Clinical › Comorbidities · 19 Aug 2025 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
-
Meeting a protein target on a suppressed appetite Replied, post #16 · Nutrition & Training › Protein & intake · 18 Aug 2025 · 24 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
When a preprint is the best available evidence and we say so Replied, post #56 · Evidence › Preprints · 14 Aug 2025 · 3 likes This follows post #53 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
How to research a compound with no human data without deceiving yourself Replied, post #108 · Compounds › Other compounds · 4 Aug 2025 · 10 likes post #107 is right about the mechanism and I think understates the practical bit. Naming conventions for research peptides cause confusion because suppliers do not…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #60 · Evidence › Trials · 21 Jul 2025 · 22 likes post #59 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2025 · 4 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Repeatability versus intermediate precision Replied, post #128 · Analytics › Method validation · 3 Jul 2025 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #42 · Compounds › Semaglutide · 25 Jun 2025 · 27 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #141 · Evidence › Journal club · 20 Jun 2025 · 3 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #12 · Sourcing › Regulatory · 26 May 2025 · 25 likes post #11 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Which panel is worth repeating and which is worth ignoring Replied, post #11 · Clinical › Bloodwork · 30 Apr 2025 · 12 likes This follows post #8 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #28 · Sourcing › Independent verification · 28 Apr 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #38 · Compounds › Secretagogues & GH axis · 7 Apr 2025 · 2 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #57 · Analytics › Mass spectrometry · 5 Apr 2025 · 5 likes Picking up post #54: that is the part I would want checked first. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error…
-
Maintainer handover: how it works Replied, post #44 · Meta › Wiki maintenance · 16 Mar 2025 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #17 · Access › Insurance & coverage · 14 Mar 2025 · 3 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #55 · Evidence › Journal club · 12 Mar 2025 · 27 likes This follows post #52 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #111 · Data & Tools › Calculators · 2 Mar 2025 · 7 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #33 · Documentation › Doc review · 6 Feb 2025 · 1 like I read post #31 twice before replying, because I had assumed the opposite. New maintainer recruitment: if a page's maintainer is inactive and updates are needed,…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #135 · Compounds › Tirzepatide · 7 Jan 2025 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #147 · Analytics › COA interpretation · 11 Dec 2024 · 9 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Revisiting: Moderation log format change Replied, post #54 · Meta › Announcements · 4 Dec 2024 · 6 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Identical chromatograms across two different lots Replied, post #50 · Sourcing › Red flags · 16 Nov 2024 · 18 likes This follows post #47 rather than contradicting it. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #99 · Compounds › Other compounds · 7 Nov 2024 · 26 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Time to steady state after a dose increase Replied, post #101 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #24 · Pharmacology › Formulation chemistry · 28 Oct 2024 · 5 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #8 · Clinical › Prescriber conversations · 26 Oct 2024 · 0 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #20 · Access › Shortages · 9 Oct 2024 · 32 likes Worth separating two things that post #16 runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply…
-
Progressive overload when the scale is falling — one year on Replied, post #113 · Nutrition & Training › Resistance training · 2 Oct 2024 · 32 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #13 · Clinical › Special populations · 2 Sep 2024 · 1 like Picking up post #10: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #86 · Research Methods › Statistics · 23 Aug 2024 · 0 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #3 · Sourcing › Independent verification · 16 Aug 2024 · 19 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…